Want to join the conversation?
Bayer agreed to acquire $MON in an all-cash transaction for a total value of $66Bil or $128 per share, which represents 44% premium to Monsanto shareholders. The company's BoD, Bayer's Board of Management and Supervisory Board have unanimously approved the agreement.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.